Castle Biosciences Inc (CSTL)

Überblick Nachrichten Preisverlauf Optionskette Financials Warum fällt CSTL? Forum Prognose

Finanzdaten der Castle Biosciences Inc-Aktie (CSTL)

*Alle Zahlen in Millionen

Enddatum des Zeitraums	2024-03-31	2023-12-31	2023-09-30	2023-06-30	2023-03-31
Periodenlänge	3 Monate	3 Monate	3 Monate	3 Monate	3 Monate
Revenues	10.37% 72.97	66.12	61.49	50.14	42.04
Cost Of Revenue	11.84% 13.89	12.42	11.32	11.06	10.18
Gross Profit	10.02% 59.08	53.70	50.17	39.08	31.86
Operating Expenses	8.75% 64.55	59.35	59.81	60.24	63.38
Interest Income/Expense	600.00% 0.014	0.002	0.002	0.003	0.004
Benefits Costs and Expenses	-	-	-	-	-
Costs And Expenses	9.29% 78.44	71.78	71.13	71.30	73.56
Operating Income/Loss	3.31% -5.471	-5.658	-9.64	-21.16	-31.52
Income/Loss From Continuing Operations Before Tax	10.37% 72.97	66.12	61.49	-18.78	-29.20
Income Tax Expense/Benefit, Deferred	100.00% -	-0.236	-	-	0.013
Income Tax Expense/Benefit	15.38% 0.045	0.039	0.032	0.016	0.014
Income/Loss From Continuing Operations After Tax	1.78% -2.534	-2.58	-6.905	-18.78	-29.20
Net Income/Loss	1.78% -2.534	-2.58	-6.905	-18.78	-29.20
Preferred Stock Dividends And Other Adjustments	-	-	-	-	-
Attributable To Noncontrolling Interest	-	-	-	-	-
Basic Average Shares	35,595% 27.48	0.077	26.83	26.73	26.61
Diluted Average Shares	35,595% 27.48	0.077	26.83	26.73	26.61
Basic Earnings Per Share	0.00% -0.09	-0.09	-0.26	-0.70	-1.10
Diluted Earnings Per Share	0.00% -0.09	-0.09	-0.26	-0.70	-1.10
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic	-	-	-	-	-

NTRA

$153.42

5.04%

$238.64

1.46%

ILMN

$130.74

3.19%

WAT

$355.47

0.83%

MTD

$1,174.56

0.43%

IDXX

$419.83

0.26%